エフリンA型受容体10タンパク質 - Oxford Biotoherapeutoix L.T.D.

Title:

エフリンA型受容体10タンパク質

Document Type and Number:

Japanese Patent JP2011509079

Kind Code:

A

Abstract:

The present invention provides methods and compositions for treatment, screening, diagnosis and prognosis of bladder cancer, breast cancer, colorectal cancer, head and neck cancer, kidney cancer, lung cancer or pancreatic cancer, for monitoring the effectiveness of bladder cancer, breast cancer, colorectal cancer, head and neck cancer, kidney cancer, lung cancer or pancreatic cancer treatment, and for drug development based on Ephrin Type-A Receptor 10 Protein.

More Like This:

JP2000506373	[Title of Invention] TGFβ signaling protein, gene and its use
JP5540504	Microorganisms that produce L-amino acids and methods for producing L-amino acids
JP5903103	Human neural stem cells expressing human choline acetyltransferase and their uses

Inventors:

Kfrist Ian Rohlov
Alasdile Stamps

Application Number:

JP2010540186A

Publication Date:

March 24, 2011

Filing Date:

December 24, 2008

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Oxford Biotoherapeutoix L.T.D.

International Classes:

C12N15/09; A61K31/7088; A61K38/00; A61K39/395; A61K45/00; A61K48/00; A61K49/00; A61P35/00; C07K14/705; C07K16/28; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12Q1/02; G01N33/15; G01N33/50; G01N33/574; G01N33/577; C12P21/08

Other References:

JPN6013048644; Ｂｉｏｃｈｅｍｉｃａｌ　ａｎｄ　Ｂｉｏｐｈｙｓｉｃａｌ　Ｒｅｓｅａｒｃｈ　ＣｏｍｍｕｎｉｃａｔｉｏｎｓＶｏｌ．３１８, 2004, ｐ．８８２-８９２
JPN6013048647; Ｂｉｏｃｈｅｍｉｃａｌ　ａｎｄ　Ｂｉｏｐｈｙｓｉｃａｌ　Ｒｅｓｅａｒｃｈ　ＣｏｍｍｕｎｉｃａｔｉｏｎｓＶｏｌ．３４２, 2006, ｐ．１２６３-１２７２
JPN6013048649; Ｂｉｏｃｈｉｍｉｃａ　ｅｔ　Ｂｉｏｐｈｙｓｉｃａ　ＡｃｔａＶｏｌ．１７２３, 2005, ｐ．１-７

Attorney, Agent or Firm:

Toru Ishikawa

Previous Patent: 乳癌発現プロファイリング

Next Patent: ＥＦＭＲ（女性に限られた癲癇及び精神遅滞）の診断方法及び治療方法